Schneider, Mark J.

Targeted Disruption of the Type 2 Selenodeiodinase Gene (DIO 2) Results in a Phenotype of Pituitary Resistance to T4

Schneider, M. J., Fiering, S. N., Pallud, S. E., Parlow, A. F., St. Germain, D. L., & Galton, V. A. (2001) · Molecular Endocrinology

Thyroid Disorders and TreatmentsSelenium in Biological Systems

Cited by 376

Targeted Disruption of the Type 1 Selenodeiodinase Gene (Dio1) Results in Marked Changes in Thyroid Hormone Economy in Mice

Schneider, M. J., Fiering, S. N., Thai, B., Wu, S.-Y., St. Germain, E., Parlow, A. F., St. Germain, D. L., & Galton, V. A. (2006) · Endocrinology

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 265

The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating development in rana catesbeiana tadpoles

Becker, K. B., Stephens, K. C., Davey, J. C., Schneider, M. J., & Galton, V. A. (1997) · Endocrinology

Thyroid Disorders and TreatmentsDevelopmental Biology and Gene Regulation

Cited by 185

Life without Thyroxine to 3,5,3′-Triiodothyronine Conversion: Studies in Mice Devoid of the 5′-Deiodinases

Galton, V. A., Schneider, M. J., Clark, A. S., & St. Germain, D. L. (2009) · Endocrinology

Thyroid Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 181